PA
GNCA

Perceptive Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

Perceptive Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,164
Closed -$71K – 226
2016
Q2 		$71K Sell
2,164
-62,413
-97% -$2.29M ﹤0.01% 155
2016
Q1 		$4M Buy
+64,577
New +$2.05M 0.35% 63

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Perceptive Advisors's GNCA Position: Q3 2016 in Review

Perceptive Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2016, closing a stake of 2,164 shares — an estimated $71K sold.

Perceptive Advisors first reported a position in GNCA in Q1 2016 and held it in 2 quarters. The position peaked at $4M in Q1 2016. 48 funds tracked by Wall St. Rank hold GNCA as of Q3 2016.

  • Perceptive Advisors reported no remaining Genocea Biosciences, Inc. position as of Q3 2016 after selling out during the quarter.
  • Perceptive Advisors sold 2,164 Genocea Biosciences, Inc. shares in Q3 2016, an estimated $71K.
  • Perceptive Advisors first reported a position in Genocea Biosciences, Inc. in Q1 2016 and held it in 2 quarters.
  • Perceptive Advisors's Genocea Biosciences, Inc. position peaked at $4M in Q1 2016.
  • 48 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2016.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.